Latest news with #Mapmygenome
Fashion Value Chain
11-06-2025
- Business
- Fashion Value Chain
Trailblazing Women in STEM and Education Experts Lead Jury for USD 30,000 DETermined Scholarship by Duolingo English Test
The Duolingo English Test (DET), has announced a six-member jury of accomplished leaders across science, technology, education and entrepreneurship for the DETermined Scholarship: a $30,000 grant aimed at supporting Indian women pursuing undergraduate or postgraduate STEM degrees in the United States at universities that accept the Duolingo English Test (DET). Applications are open until 30th June, and interested candidates can access the application portal at Manthan and complete their submissions online. The scholarship is designed to identify women who combine academic excellence with leadership and a commitment to building India's innovation future. The jury reflects that mission, bringing together diverse and distinguished perspectives to select a scholar who will thrive academically and contribute to India's innovation story. Six-member jury for the DETermined Scholarship, including (L-R, top to bottom): Dr. Sapna Poti, Kirthiga Reddy, Anuradha Acharya, Arnav Kumar, Jennifer Dewar, Carrie Wang The 2025 DETermined Scholarship Jury Panel Includes: Dr. Sapna Poti , Director, Strategic Alliances, Office of the Principal Scientific Adviser Kirthiga Reddy , CEO, Verix and Former Managing Director of Facebook in India and South Asia Anuradha Acharya , CEO, Mapmygenome Arnav Kumar , Co-founder, Leap Carrie Wang , Senior Director, Head of Growth, Duolingo English Test Jennifer Dewar, Senior Director of Strategic Engagement, Duolingo English Test At the heart of the panel are two pioneering women who serve as powerful role models for Indian women in STEM. Kirthiga Reddy is a leader who studied in the U.S. and brings a personal perspective rooted in identifying foundational strengths and establishing longer-term vision. She is also deeply involved with the education community through her position on the board of trustees at Syracuse University and as a former chair of the Stanford Business School Management Board. Anuradha Acharya founded Mapmygenome, a leading genomics company, to highlight the impact of global access to build, scale and drive innovation back in India. Her leadership is also pivotal in inspiring innovation amongst future generations of female achievers in India. Dr. Sapna Poti, representing the Office of the Principal Scientific Adviser to the Government of India and a strong advocate for gender diversity in STEM, brings to the panel a focus on selecting candidates who can drive meaningful technological change in India. Reflecting on her role, she said, 'Supporting talented women in science and technology through scholarships and mentorship is essential to advancing India's innovation landscape. This jury represents the power of women breaking barriers in STEM, inspiring the next generation.' Arnav Kumar, Co-founder of Leap and an expert in guiding Indian students through global education pathways, brings a deep understanding of the challenges students face when pursuing studies abroad. 'Beyond financial aid, what Indian students need is guidance and a pathway to global exposure that builds lasting impact. The DETermined Scholarship not only funds dreams but also connects the recipient with a network and vision that help them lead change when they return. I aim to help select someone with the determination and drive to make the most of this opportunity in the longer term.' Also on the panel are Carrie Wang and Jennifer Dewar from the Duolingo English Test. Their deep experience in global education and student engagement further strengthens the scholarship's focus on access, equity and future-ready learning. Together, the panel brings a holistic lens to identifying talent, balancing academic merit with leadership, vision and a purpose-driven mindset. The DETermined Scholarship isn't just about access; it's about investing in a generation of Indian women who will shape the future of STEM in India and on the world stage. About Duolingo English Test The Duolingo English Test (DET) is a convenient, fast and affordable English proficiency test, designed with the test taker in mind. By integrating the latest assessment science and AI, the test empowers anyone to certify their English when and where they're at their best. A combination of rigorous security protocols, AI, and remote proctoring ensures the integrity of the test. DET test scores are accepted by over 5800 institutions worldwide, including Columbia, University of Toronto, University of Warwick and Yale.
Fashion Value Chain
11-06-2025
- Business
- Fashion Value Chain
Trailblazing Women in STEM and Education Experts Lead Jury for USD 30,0000 DETermined Scholarship by Duolingo English Test
The Duolingo English Test (DET), has announced a six-member jury of accomplished leaders across science, technology, education and entrepreneurship for the DETermined Scholarship: a $30,000 grant aimed at supporting Indian women pursuing undergraduate or postgraduate STEM degrees in the United States at universities that accept the Duolingo English Test (DET). Applications are open until 30th June, and interested candidates can access the application portal at Manthan and complete their submissions online. The scholarship is designed to identify women who combine academic excellence with leadership and a commitment to building India's innovation future. The jury reflects that mission, bringing together diverse and distinguished perspectives to select a scholar who will thrive academically and contribute to India's innovation story. Six-member jury for the DETermined Scholarship, including (L-R, top to bottom): Dr. Sapna Poti, Kirthiga Reddy, Anuradha Acharya, Arnav Kumar, Jennifer Dewar, Carrie Wang The 2025 DETermined Scholarship Jury Panel Includes: Dr. Sapna Poti , Director, Strategic Alliances, Office of the Principal Scientific Adviser Kirthiga Reddy , CEO, Verix and Former Managing Director of Facebook in India and South Asia Anuradha Acharya , CEO, Mapmygenome Arnav Kumar , Co-founder, Leap Carrie Wang , Senior Director, Head of Growth, Duolingo English Test Jennifer Dewar, Senior Director of Strategic Engagement, Duolingo English Test At the heart of the panel are two pioneering women who serve as powerful role models for Indian women in STEM. Kirthiga Reddy is a leader who studied in the U.S. and brings a personal perspective rooted in identifying foundational strengths and establishing longer-term vision. She is also deeply involved with the education community through her position on the board of trustees at Syracuse University and as a former chair of the Stanford Business School Management Board. Anuradha Acharya founded Mapmygenome, a leading genomics company, to highlight the impact of global access to build, scale and drive innovation back in India. Her leadership is also pivotal in inspiring innovation amongst future generations of female achievers in India. Dr. Sapna Poti, representing the Office of the Principal Scientific Adviser to the Government of India and a strong advocate for gender diversity in STEM, brings to the panel a focus on selecting candidates who can drive meaningful technological change in India. Reflecting on her role, she said, 'Supporting talented women in science and technology through scholarships and mentorship is essential to advancing India's innovation landscape. This jury represents the power of women breaking barriers in STEM, inspiring the next generation.' Arnav Kumar, Co-founder of Leap and an expert in guiding Indian students through global education pathways, brings a deep understanding of the challenges students face when pursuing studies abroad. 'Beyond financial aid, what Indian students need is guidance and a pathway to global exposure that builds lasting impact. The DETermined Scholarship not only funds dreams but also connects the recipient with a network and vision that help them lead change when they return. I aim to help select someone with the determination and drive to make the most of this opportunity in the longer term.' Also on the panel are Carrie Wang and Jennifer Dewar from the Duolingo English Test. Their deep experience in global education and student engagement further strengthens the scholarship's focus on access, equity and future-ready learning. Together, the panel brings a holistic lens to identifying talent, balancing academic merit with leadership, vision and a purpose-driven mindset. The DETermined Scholarship isn't just about access; it's about investing in a generation of Indian women who will shape the future of STEM in India and on the world stage. About Duolingo English Test The Duolingo English Test (DET) is a convenient, fast and affordable English proficiency test, designed with the test taker in mind. By integrating the latest assessment science and AI, the test empowers anyone to certify their English when and where they're at their best. A combination of rigorous security protocols, AI, and remote proctoring ensures the integrity of the test. DET test scores are accepted by over 5800 institutions worldwide, including Columbia, University of Toronto, University of Warwick and Yale.
Time of India
29-05-2025
- Business
- Time of India
Mapmygenome acquires Canadian CRO Microbiome Insights
HYDERABAD: AI-driven genomics and personalised health player Mapmygenome has acquired Canadian microbial sequencing player Microbiome Insights. The acquisition includes the CAP-accredited (College of American Pathologists) Canadian laboratory of Microbiome Insights as well as its intellectual property. Though the Hyderabad-based Mapmygenome did not divulge the size of acquisition, its founder & CEO Anu Acharya confirmed that it had acquired 100% stake in the 10-year-old Canadian company. She said the acquisition would boost Mapmygenome's scientific prowess and enable its global expansion. Microbiome Insights, which has supported over 600 global clients with more than 1,000 cutting-edge microbiome studies, is a leading partner for academic, clinical, and industry researchers. It was founded by renowned global experts such as Dr Brett Finlay, Dr William Mohn, and Malcolm Kendall. While post-acquisition Microbiome Insights will maintain its role as a premier CRO (clinical research organisation), Mapmygenome said it will roll out its integrated genomics and microbiome testing services to North America to make holistic, data-driven health solutions more accessible. 'The human microbiome is pivotal to health, and this acquisition positions us as a leader in this area. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Esta nueva alarma con cámara es casi regalada en Sarandí (ver precio) Verisure Undo We gain exceptional expertise in metagenomics, transcriptomics, and targeted metabolomics to serve academic, biotech, and clinical sectors,' said Acharya. She said the buy will accelerate the company's North American footprint, aligning with Mapmygenome's strategic vision of growth through targeted acquisitions as it works towards its listing on the Indian bourses later this year. Microbiome Insights CEO Malcolm Kendall said the deal would provide the company the resources and capabilities to offer higher quality services to clients and accelerate growth. Microbiome Insights offers end-to-end microbiome sequencing and comprehensive bioinformatic analysis for sectors such as pharma, biotech, nutrition, cosmetics, agriculture as well as government institutions and has enabled over 1,000 studies. These range from basic research to clinical trials, and biomarker discovery to machine-learning based modelling. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Cision Canada
29-05-2025
- Business
- Cision Canada
Mapmygenome cements global leadership in Genomics with strategic acquisition of Canada's Microbiome Insights
HYDERABAD, India and VANCOUVER, BC, May 29, 2025 /CNW/ -- Mapmygenome, an AI-driven leader in genomics and personalized health, announced the strategic acquisition of Microbiome Insights, a global leader in microbial sequencing. The acquisition includes Microbiome Insights' CAP-accredited Canadian laboratory and rich intellectual property, boosting Mapmygenome's scientific prowess and enabling its global expansion. Having supported over 600 global clients with 1,000+ cutting-edge microbiome studies, Microbiome Insights is a leading partner for academic, clinical, and industry researchers. Its founders, Dr. Brett Finlay, Dr. William Mohn, and Malcolm Kendall, are recognized global experts. Microbiome Insights will maintain its role as a premier CRO, empowering global research. Simultaneously, Mapmygenome will introduce its integrated genomics and microbiome testing services to North America, making holistic, data-driven health solutions more accessible. "The human microbiome is pivotal to health, and this acquisition positions us as a leader in this area. We gain exceptional expertise in metagenomics, transcriptomics, and targeted metabolomics to serve academic, biotech, and clinical sectors," declared Anu Acharya, Founder and CEO of Mapmygenome. "This accelerates our North American footprint aligning with our strategic vision of growth through targeted acquisitions leading up to our listing on the Indian market later this year" "Joining forces with Mapmygenome, provides the resources and capabilities to offer higher quality services to our clients and accelerate growth. The combination of their expertise in AI-driven genomics solutions and our deep microbiome expertise will result in a new standard of cutting-edge services for clients worldwide," said Malcolm Kendall, CEO of Microbiome Insights. Financial terms were not disclosed. About Mapmygenome: Founded a decade ago, we are a leading genomics company driven by pioneering research and a vision for preventive healthcare. We harness AI-driven genomic and microbiome testing to deliver personalized health solutions, with offerings like at-home DNA tests for proactive health and longevity. For healthcare providers, our diagnostic genomic tests are conducted in a CAP-accredited lab, ensuring high accuracy, complemented by genetic counseling. About Microbiome Insights: We are a global leader providing end-to-end microbiome sequencing and comprehensive bioinformatic analysis. Collaborating with pharma, biotech, nutrition, cosmetic, and agriculture clients, alongside leading academic and government institutions, we've supported over 1,000 studies, from basic research to clinical trials, and biomarker discovery to machine-learning based modeling.
Business Standard
29-05-2025
- Business
- Business Standard
Mapmygenome cements global leadership in Genomics with strategic acquisition of Canada's Microbiome Insights
PRNewswire Hyderabad (Telangana) [India] / Vancouver (British Columbia) [Canada], May 29: Mapmygenome, an AI-driven leader in genomics and personalized health, announced the strategic acquisition of Microbiome Insights, a global leader in microbial sequencing. The acquisition includes Microbiome Insights' CAP-accredited Canadian laboratory and rich intellectual property, boosting Mapmygenome's scientific prowess and enabling its global expansion. Having supported over 600 global clients with 1,000+ cutting-edge microbiome studies, Microbiome Insights is a leading partner for academic, clinical, and industry researchers. Its founders, Dr. Brett Finlay, Dr. William Mohn, and Malcolm Kendall, are recognized global experts. Microbiome Insights will maintain its role as a premier CRO, empowering global research. Simultaneously, Mapmygenome will introduce its integrated genomics and microbiome testing services to North America, making holistic, data-driven health solutions more accessible. "The human microbiome is pivotal to health, and this acquisition positions us as a leader in this area. We gain exceptional expertise in metagenomics, transcriptomics, and targeted metabolomics to serve academic, biotech, and clinical sectors," declared Anu Acharya, Founder and CEO of Mapmygenome. "This accelerates our North American footprint aligning with our strategic vision of growth through targeted acquisitions leading up to our listing on the Indian market later this year" "Joining forces with Mapmygenome, provides the resources and capabilities to offer higher quality services to our clients and accelerate growth. The combination of their expertise in AI-driven genomics solutions and our deep microbiome expertise will result in a new standard of cutting-edge services for clients worldwide," said Malcolm Kendall, CEO of Microbiome Insights. Financial terms were not disclosed. About Mapmygenome: Founded a decade ago, we are a leading genomics company driven by pioneering research and a vision for preventive healthcare. We harness AI-driven genomic and microbiome testing to deliver personalized health solutions, with offerings like at-home DNA tests for proactive health and longevity. For healthcare providers, our diagnostic genomic tests are conducted in a CAP-accredited lab, ensuring high accuracy, complemented by genetic counseling. About Microbiome Insights: We are a global leader providing end-to-end microbiome sequencing and comprehensive bioinformatic analysis. Collaborating with pharma, biotech, nutrition, cosmetic, and agriculture clients, alongside leading academic and government institutions, we've supported over 1,000 studies, from basic research to clinical trials, and biomarker discovery to machine-learning based modeling.
